858
Views
35
CrossRef citations to date
0
Altmetric
Research Article

Drug-induced seizures in children and adolescents presenting for emergency care: Current and emerging trends

, , , , &
Pages 761-766 | Received 27 Dec 2012, Accepted 22 Jul 2013, Published online: 19 Aug 2013

References

  • Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994; 35:S1–S6.
  • Hauser WA. Epidemiology of epilepsy in children. Neurosurg Clin N Am 1995; 6:419–429.
  • Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med 2002; 22:235–239.
  • Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology 1993; 43:483–488.
  • Bond GR, Woodward RW, Ho M. The growing impact of pediatric pharmaceutical poisoning. J Pediatr 2012; 160:265–270.e1.
  • Wax PM, Kleinschmidt KC, Brent J. The Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol 2011; 7:259–265.
  • Finkelstein Y, Hutson JR, Wax PM, Brent J. Toxico-Surveillance of Infant and Toddler Poisonings in the United States. J Med Toxicol 2012; 8:263–266.
  • Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol 2007; 3:15–19.
  • Olson KR, Kearney TE, Dyer JE, Benowitz NL, Blanc PD. Seizures associated with poisoning and drug overdose. Am J Emerg Med 1994; 12:392–395.
  • Reidy L, Walls HC, Steele BW. Cross-reactivity of bupropion metabolite with enzyme-linked immunosorbent assays designed to detect amphetamine in urine. Ther Drug Monit 2011; 33:366–368.
  • Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: a case series. Med J Aust 2003; 178:61–63.
  • Spiller HA, Bosse GM, Beuhler M, Gray T, Baker SD. Unintentional ingestion of bupropion in children. J Emerg Med 2010; 38:332–336.
  • Beuhler MC, Spiller HA, Sasser HC. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. J Med Toxicol 2010; 6:4–8.
  • Shenoi AN, Gertz SJ, Mikkilineni S, Kalyanaraman M. Refractory hypotension from massive bupropion overdose successfully treated with extracorporeal membrane oxygenation. Pediatr Emerg Care 2011;27:43–45.
  • Mainie I, McGurk C, McClintock G, Robinson J. Seizures after buproprion overdose. Lancet 2001; 357:1624.
  • Spiller HA, Schaeffer SE. Multiple seizures after bupropion overdose in a small child. Pediatr Emerg Care 2008; 24:474–475.
  • Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989; 50:256–261.
  • Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther 2012; 34:113–123.
  • Wallace KL. Toxin-induced seizures. In: J Brent, KL Wallace, KK Burkhart, SD Phillips, Donovan JW, eds. Critical Care Toxicology: Diagnosis and Management of the Critically Poisoned Patient. Philadelphia: Elsevier Mosby; 2005:225–239.
  • Shah AS, Eddleston M. Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures?Clin Toxicol (Phila) 2010; 48:800–805.
  • Osterhoudt KC, Henretig FM. A 16-year-old with recalcitrant seizures. Pediatr Emerg Care 2012; 28:304–306.
  • Pant S, Deshmukh A, Dholaria B, Kaur V, Ramavaram S, Ukor M, Teran GA. Spicy seizure. Am J Med Sci 2012; 344:67–68.
  • American Association of Poison Control Centers. AAPCC Issues Statement on the Synthetic Drug Abuse Prevention Act. 2012. Available at: http://www.aapcc.org/dnn/Portals/0/StatementonSigningofSyntheticDrugAct7.2012.pdf
  • Simmons J, Cookman L, Kang C, Skinner C. Three cases of “spice” exposure. Clin Toxicol (Phila) 2011; 49:431–433.
  • Lapoint J, James LP, Moran CL, Nelson LS, Hoffman RS, Moran JH. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila) 2011; 49:760–764.
  • Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A Characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012; 60:435–438.
  • Schneir AB, Baumbacher T. Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol 2012; 8:62–64.
  • Havenon AD, Chin B, Thomas KC, Afra P. The secret “spice”: an undetectable toxic cause of seizure. The Neurohospitalist 2011; 1:182–186.
  • Brent J, Wax PM, Schwartz T, Kleinschmidt KC, Engebretsen K, Beuhler M. The Toxicology Investigators Consortium Case Registry–The 2010 experience. J Med Toxicol 2011; 7:266–276.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.